Total Funding
79
33
Total FundingSeed raised
Growth Score
-8 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1011851
VivaBioCell develops products based on cell culture and tissue engineering for the diagnosis of autoimmune diseases.
Francesco Curcio: Chief Scientific Officer, President & Founder
About the Company
VivaBioCell is a company developing innovative products, coming from proprietary technologies in cell culture and tissue engineering, to fit unmet medical needs and aimed to early diagnosis of autoimmune diseases (scleroderma, graft versus host disease) and treatment of oro-dental and maxillo-facial defects.
VivaBioCell intends to perform these
activities by means of owned, already developed technologies, by setting-up new innovative technologies and by identifying new opportunities through the collaborations with recognised academic research centres, in particular in Italy.
